Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schultz

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
The American Journal of Cardiology|May 4, 2024
Association Between Vegetation Size and Outcome in the Partial Oral Antibiotic Endocarditis Treatment TrialRasmus Carter-Storch, Mia Marie Pries-Heje, Jonas A Povlsen, et al.
Heart (British Cardiac Society)|October 6, 2021
Severity of anaemia and association with all-cause mortality in patients with medically managed left-sided endocarditisMia Marie Pries-Heje, Rasmus Bo Hasselbalch, Christoffer Wiingaard, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 29, 2022
Self-assessed health status and associated mortality in endocarditis: secondary findings from the POET trialJohan S Bundgaard, Kasper Iversen, Mia Pries-Heje, et al.
The New England Journal of Medicine|February 9, 2022
Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) TrialMia M Pries-Heje, Christoffer Wiingaard, Nikolaj Ihlemann, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|August 30, 2018
Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)Martin Schultz, Line Jee Hartmann Rasmussen, Malene H Andersen, et al.
Environmental Science & Technology|September 22, 2009
Intercontinental impacts of ozone pollution on human mortalitySusan Casper Anenberg, I Jason West, Arlene M Fiore, et al.
Resuscitation Plus|July 5, 2021
Vasopressin and methylprednisolone for in-hospital cardiac arrest - Protocol for a randomized, double-blind, placebo-controlled trialLars W Andersen, Birthe Sindberg, Mathias Holmberg, et al.
Journal of Psychosomatic Research|January 25, 2022
The impact of partial-oral endocarditis treatment on anxiety and depression in the POET trialJohan S Bundgaard, Kasper Iversen, Mia Pries-Heje, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 22, 2023
Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET SubstudyMagnus Bock, Anna Marie Theut, Johan G C van Hasselt, et al.
Resuscitation|May 1, 2022
Effect of vasopressin and methylprednisolone vs. placebo on long-term outcomes in patients with in-hospital cardiac arrest a randomized clinical trialAsger Granfeldt, Birthe Sindberg, Dan Isbye, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
The American Journal of Cardiology|May 4, 2024
Association Between Vegetation Size and Outcome in the Partial Oral Antibiotic Endocarditis Treatment TrialRasmus Carter-Storch, Mia Marie Pries-Heje, Jonas A Povlsen, et al.
Heart (British Cardiac Society)|October 6, 2021
Severity of anaemia and association with all-cause mortality in patients with medically managed left-sided endocarditisMia Marie Pries-Heje, Rasmus Bo Hasselbalch, Christoffer Wiingaard, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 29, 2022
Self-assessed health status and associated mortality in endocarditis: secondary findings from the POET trialJohan S Bundgaard, Kasper Iversen, Mia Pries-Heje, et al.
The New England Journal of Medicine|February 9, 2022
Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) TrialMia M Pries-Heje, Christoffer Wiingaard, Nikolaj Ihlemann, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|August 30, 2018
Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)Martin Schultz, Line Jee Hartmann Rasmussen, Malene H Andersen, et al.
Environmental Science & Technology|September 22, 2009
Intercontinental impacts of ozone pollution on human mortalitySusan Casper Anenberg, I Jason West, Arlene M Fiore, et al.
Resuscitation Plus|July 5, 2021
Vasopressin and methylprednisolone for in-hospital cardiac arrest - Protocol for a randomized, double-blind, placebo-controlled trialLars W Andersen, Birthe Sindberg, Mathias Holmberg, et al.
Journal of Psychosomatic Research|January 25, 2022
The impact of partial-oral endocarditis treatment on anxiety and depression in the POET trialJohan S Bundgaard, Kasper Iversen, Mia Pries-Heje, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 22, 2023
Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET SubstudyMagnus Bock, Anna Marie Theut, Johan G C van Hasselt, et al.
Resuscitation|May 1, 2022
Effect of vasopressin and methylprednisolone vs. placebo on long-term outcomes in patients with in-hospital cardiac arrest a randomized clinical trialAsger Granfeldt, Birthe Sindberg, Dan Isbye, et al.
Pageof 8